Last 7 days
-20.8%
Last 30 days
-56.7%
Last 90 days
-44.6%
Trailing 12 Months
-95.7%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
CHTR | 54.3B | 54.0B | -10.11% | -38.51% | 10.75 | 1.01 | 4.53% | 8.62% |
OMC | 17.8B | 14.3B | -4.59% | 5.37% | 13.49 | 1.24 | 0.00% | -6.49% |
SIRI | 14.7B | 9.0B | -14.32% | -41.38% | 12.09 | 1.63 | 3.53% | -7.69% |
IPG | 13.5B | 10.9B | -4.05% | -1.69% | 14.44 | 1.24 | 6.71% | -1.55% |
MID-CAP | ||||||||
NXST | 6.3B | 5.2B | -5.92% | -2.26% | 6.48 | 1.21 | 12.10% | 16.37% |
DISH | 4.6B | 16.7B | -33.10% | -71.68% | 1.96 | 0.28 | -6.72% | -3.38% |
SMALL-CAP | ||||||||
CRTO | 1.9B | 2.0B | -12.63% | 8.83% | 210.69 | 0.94 | -10.52% | -93.34% |
TTGT | 1.0B | 297.5M | -8.85% | -56.76% | 24.71 | 3.46 | 12.93% | 4284.51% |
CCO | 738.0M | 2.5B | -36.42% | -70.27% | -5.57 | 0.29 | 10.71% | 77.73% |
IHRT | 595.8M | 3.9B | -46.88% | -79.34% | -2.25 | 0.15 | 9.95% | -66.25% |
EEX | 244.0M | 325.9M | -5.99% | -0.82% | 2.45 | 0.75 | 123.99% | 195.03% |
SCOR | 102.2M | 376.4M | -5.13% | -58.27% | -1.54 | 0.27 | 2.56% | -33.02% |
CDLX | 88.0M | 298.5M | -56.73% | -95.70% | -0.19 | 0.29 | 11.76% | -261.89% |
SGRP | 40.0M | 256.6M | -3.79% | -5.93% | -28.86 | 0.16 | 0.62% | -122.10% |
CREX | 13.9M | 38.3M | -12.65% | -25.48% | 6.77 | 0.36 | 112.29% | 53.70% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -2.5% | 298,542,000 | 306,088,000 | 298,366,000 | 281,814,000 | 267,116,000 |
S&GA Expenses | -2.8% | 74,745,000 | 76,918,000 | 75,362,000 | 70,442,000 | 65,996,000 |
R&D Expenses | 5.8% | 54,435,000 | 51,445,000 | 48,824,000 | 44,177,000 | 38,104,000 |
EBITDA | -491.7% | -434,819,000 | -73,490,000 | -128,992,000 | -52,284,000 | - |
EBITDA Margin | -506.6% | -1.46 | -0.24 | -0.43 | -0.19 | - |
Earnings Before Taxes | -331.6% | -466,710,000 | -108,130,000 | -158,926,000 | -78,496,000 | -136,429,000 |
EBT Margin | -342.5% | -1.56 | -0.35 | -0.53 | -0.28 | - |
Interest Expenses | 31.6% | -5,653,000 | -8,266,000 | -10,465,000 | -12,563,000 | - |
Net Income | -370.8% | -465,264,000 | -98,820,000 | -149,616,000 | -70,632,000 | -128,565,000 |
Net Income Margin | -382.7% | -1.56 | -0.32 | -0.50 | -0.25 | - |
Free Cahsflow | -26.9% | -55,075,000 | -43,411,000 | -39,589,000 | -47,810,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -35.2% | 691 | 1,066 | 1,090 | 1,231 | 1,264 |
Current Assets | 0.4% | 250 | 249 | 264 | 319 | 359 |
Cash Equivalents | -11.9% | 122 | 139 | 157 | 208 | 233 |
Net PPE | -16.7% | 6.00 | 7.00 | 9.00 | 10.00 | 11.00 |
Goodwill | -47.0% | 353 | 666 | 666 | 748 | 743 |
Liabilities | -1.3% | 480 | 486 | 525 | 520 | 573 |
Current Liabilities | -2.3% | 249 | 255 | 294 | 247 | 327 |
Long Term Debt | - | 184 | - | - | - | - |
Shareholder's Equity | -63.5% | 212 | 581 | 564 | 712 | 691 |
Retained Earnings | -63.2% | -976 | -598 | -604 | -478 | -522 |
Additional Paid-In Capital | 1.1% | 1,183 | 1,169 | 1,163 | 1,188 | 1,213 |
Shares Outstanding | -2.5% | 33.00 | 34.00 | 34.00 | - | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -30.3% | -53.90 | -41.36 | -37.38 | -45.68 | -38.52 |
Share Based Compensation | -0.8% | 45.00 | 45.00 | 56.00 | 57.00 | 50.00 |
Cashflow From Investing | 1.6% | -15.76 | -16.02 | -15.59 | -359 | -506 |
Cashflow From Financing | -1.0% | -39.99 | -39.58 | -39.21 | 2.00 | 486 |
Buy Backs | -25.0% | 40.00 | 53.00 | 53.00 | 0.00 | - |
99.2%
79.2%
77.7%
Y-axis is the maximum loss one would have experienced if Cardlytics was unfortunately bought at previous high price.
-30.5%
-59.3%
FIve years rolling returns for Cardlytics.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | BAILLIE GIFFORD & CO | added | 30.69 | -2,029,650 | 8,301,350 | 0.01% |
2023-02-28 | Voya Investment Management LLC | unchanged | - | -45,999 | 73,001 | -% |
2023-02-22 | CVA Family Office, LLC | unchanged | - | -2,110 | 2,890 | -% |
2023-02-21 | MACQUARIE GROUP LTD | sold off | -100 | -4,000 | - | -% |
2023-02-15 | NOMURA HOLDINGS INC | unchanged | - | -203,000 | 324,000 | -% |
2023-02-15 | MetLife Investment Management, LLC | unchanged | - | -62,966 | 101,034 | -% |
2023-02-15 | GAMCO INVESTORS, INC. ET AL | sold off | -100 | -152,000 | - | -% |
2023-02-15 | PERSONAL CAPITAL ADVISORS CORP | unchanged | - | -142,297 | 227,703 | -% |
2023-02-15 | ALLIANCEBERNSTEIN L.P. | added | 66.56 | 7,854 | 313,854 | -% |
2023-02-15 | JANE STREET GROUP, LLC | new | - | 313,322 | 313,322 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 15, 2023 | 683 capital management, llc | 5.7% | 1,883,020 | SC 13G/A | |
Feb 14, 2023 | cas investment partners, llc | 16.3% | 5,416,116 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 7.21% | 2,392,757 | SC 13G/A | |
Feb 07, 2023 | blackrock inc. | 8.2% | 2,724,485 | SC 13G/A | |
Sep 09, 2022 | wellington management group llp | 5.93% | 1,951,407 | SC 13G/A | |
Jul 21, 2022 | 683 capital management, llc | 6.4% | 2,176,659 | SC 13G | |
Jun 03, 2022 | jpmorgan chase & co | 0.4% | 153,697 | SC 13G/A | |
Feb 14, 2022 | cas investment partners, llc | 15.6% | 5,186,466 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 8.73% | 2,905,042 | SC 13G/A | |
Feb 04, 2022 | wellington management group llp | 11.58% | 3,854,015 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | - - | - - | - - | - - |
Current Inflation | 4.76 75.00% | 5.66 108.09% | 7.74 184.56% | 10.32 279.41% | 12.84 372.06% |
Very High Inflation | - - | - - | - - | - - | - - |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 22, 2023 | 8-K | Current Report | |
Mar 14, 2023 | 8-K | Current Report | |
Mar 01, 2023 | POSASR | POSASR | |
Mar 01, 2023 | POS AM | POS AM | |
Mar 01, 2023 | 8-K | Current Report | |
Mar 01, 2023 | 10-K | Annual Report | |
Feb 15, 2023 | SC 13G/A | Major Ownership Report | |
Feb 14, 2023 | SC 13G/A | Major Ownership Report | |
Feb 09, 2023 | SC 13G/A | Major Ownership Report | |
Feb 07, 2023 | SC 13G/A | Major Ownership Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-01-12 | Christiansen Andrew | acquired | - | - | 8,137 | chief financial officer |
2023-01-12 | Lynton Nicholas Hollmeyer | acquired | - | - | 6,312 | chief legal & privacy officer |
2022-12-09 | Lynton Nicholas Hollmeyer | acquired | - | - | 1,250 | chief legal & privacy officer |
2022-12-09 | Christiansen Andrew | acquired | - | - | 1,875 | chief financial officer |
2022-11-09 | BALEN JOHN V | bought | 11,398 | 3.7995 | 3,000 | - |
2022-11-08 | Grimes Scott D. | sold | -23.52 | 3.92 | -6.00 | - |
2022-11-08 | Christiansen Andrew | sold | -271 | 3.995 | -68.00 | chief financial officer |
2022-11-08 | Lynton Nicholas Hollmeyer | sold | -3.92 | 3.92 | -1.00 | chief legal & privacy officer |
2022-11-08 | BALEN JOHN V | bought | 23,698 | 3.9497 | 6,000 | - |
2022-11-08 | Grimes Scott D. | sold | -1,968 | 3.985 | -494 | - |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Revenue | $ 298,542 | $ 267,116 | $ 186,892 |
Costs and expenses: | |||
Partner Share and other third-party costs | 155,507 | 141,273 | 109,308 |
Delivery costs | 30,403 | 22,503 | 14,310 |
Sales and marketing expense | 74,745 | 65,996 | 45,307 |
Research and development expense | 54,435 | 38,104 | 17,532 |
General and administration expense | 81,446 | 66,222 | 46,532 |
Acquisition and integration costs (benefits) | (2,874) | 24,372 | 0 |
Change in fair value of contingent consideration | (128,174) | 1,374 | 0 |
Impairment of goodwill and intangible assets | 453,288 | 0 | 0 |
Depreciation and amortization expense | 37,544 | 29,871 | 7,826 |
Total costs and expenses | 756,320 | 389,715 | 240,815 |
Operating loss | (457,778) | (122,599) | (53,923) |
Other Income and Expenses [Abstract] | |||
Interest expense, net | (2,556) | (12,563) | (3,048) |
Other Nonoperating Income (Expense) | (6,376) | (1,267) | 1,549 |
Nonoperating Income (Expense), Total | (8,932) | (13,830) | (1,499) |
Loss before income taxes | (466,710) | (136,429) | (55,422) |
Income tax benefit | 1,446 | 7,864 | 0 |
Net loss | (465,264) | (128,565) | (55,422) |
Net loss attributable to common stockholders | $ (465,264) | $ (128,565) | $ (55,422) |
Earnings Per Share, Basic | $ (13.92) | $ (3.99) | $ (2.04) |
Weighted-average common shares outstanding, basic (in shares) | 33,419 | 32,202 | 27,213 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 121,905 | $ 233,467 |
Restricted cash | 80 | 95 |
Accounts receivable and contract assets, net | 115,609 | 111,085 |
Other receivables | 4,470 | 6,097 |
Prepaid expenses and other assets | 7,978 | 7,981 |
Total current assets | 250,042 | 358,725 |
Long-term assets: | ||
Property and equipment, net | 5,916 | 11,273 |
Right-of-use assets under operating leases, net | 6,571 | 10,196 |
Intangible assets, net | 53,475 | 125,550 |
Goodwill | 352,721 | 742,516 |
Capitalized software development costs, net | 19,925 | 13,131 |
Deferred implementation costs, net | 0 | 0 |
Other long-term assets, net | 2,586 | 2,406 |
Total assets | 691,236 | 1,263,797 |
Current liabilities: | ||
Accounts payable | 3,765 | 4,619 |
Accrued liabilities: | ||
Accrued compensation | 10,486 | 12,136 |
Accrued expenses | 21,335 | 19,620 |
Partner Share liability | 48,593 | 46,595 |
Consumer Incentive liability | 53,983 | 52,602 |
Deferred revenue | 1,751 | 3,280 |
Current operating lease liabilities | 4,910 | 6,028 |
contingent consideration liability, current | (104,121) | (182,470) |
Total current liabilities | 248,944 | 327,350 |
Convertible Debt, Noncurrent | 226,047 | 184,398 |
Long-term liabilities: | ||
Contract with Customer, Liability, Noncurrent | 334 | 173 |
Long-term operating lease liabilities | 4,306 | 6,801 |
contingent consideration liability, long term | 0 | (49,825) |
Other long-term liabilities | 0 | 4,550 |
Liabilities | 479,631 | 573,097 |
Stockholders’ equity: | ||
Common stock, $0.0001 par value—100,000 shares authorized and 33,534 and 33,477 shares issued and outstanding as of December 31, 2021 and December 31, 2022, respectively | 9 | 9 |
Additional paid-in capital | 1,182,568 | 1,212,823 |
Accumulated other comprehensive income | 5,598 | 486 |
Accumulated deficit | (976,570) | (522,618) |
Total stockholders’ equity | 211,605 | 690,700 |
Total liabilities and stockholders’ equity | $ 691,236 | $ 1,263,797 |